ReviewReviews in medical virology2026
Does COVID-19 Vaccination Protect Against Post-COVID Cardiovascular Conditions?
Review in Reviews in medical virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Cardiovascular diseases, such as acute myocardial infarction, heart failure, and arrhythmias, have been associated with SARS-CoV-2 infection, representing an important cause of long-term morbidity and mortality. In addition to preventing primary infection, COVID-19 vaccination has emerged as a protective factor against post-COVID cardiovascular outcomes. This study aims to analyse the evidence supporting a causal relationship between COVID-19 vaccination and the prevention of post-COVID cardiovascular conditions, based on classical and contemporary epidemiological criteria, including the Bradford Hill criteria (BHC) and the sufficient component cause (SCC) model. A qualitative synthesis of the evidence was performed according to the nine BHC and the SCC model. Scientific evidence indicates that COVID-19 vaccination meets four of the nine BHC as a protective factor against post-COVID cardiovascular conditions, namely strength of association, consistency, temporality, and biological gradient. Three criteria, biological plausibility, coherence, and analogy, were partially met. Specificity and experimental evidence were not supported by the available literature. The SCC model highlights the fundamental role of vaccination as a preventive causal component. It also contributes to two criteria, strength of association and temporality, while emphasising the limitation of specificity in causal inference. COVID-19 vaccination has proven effective beyond the acute phase of the disease, with protection extending to a reduced risk of post-COVID cardiovascular conditions. Comprehensive immunisation strategies and reinfection prevention are essential to mitigate the burden of post-COVID conditions. Additional studies are needed to explore the underlying biological mechanisms, interactions, and the role of COVID-19 vaccination in preventing post-COVID complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.